Clinical Trial Update: Assessment of the Safety and Efficacy of Ciproxan-I.V. in Daily Clinical Practice - Analysis Results From a Post-marketing Surveillance

View source ↗

Summary

Post-marketing surveillance analysis assessing safety and efficacy of Ciproxan-I.V. in daily clinical practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection

Drugs mentioned

• Ciproxan-I.V.

Snippet

Sponsor: Bayer | Conditions: Infection | Status: COMPLETED